Cited by 139T-cell and B-cell ImmunologyTransplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs

Open access
Gupta, Shipra, Thornley, Thomas B., Gao, Wenda, Larocca, Rafael, Turka, Laurence A., Kuchroo, Vijay K., Strom, Terry B.·2012·Journal of Clinical Investigation

Abstract

Tregs play a pivotal role in inducing and maintaining donor-specific transplant tolerance. The T cell immunoglobulin and mucin domain-3 protein (TIM-3) is expressed on many fully activated effector T cells. Along with program death 1 (PD-1), TIM-3 is used as a marker for exhausted effector T cells, and interaction with its ligand, galectin-9, leads to selective death of TIM-3+ cells. We report herein the presence of a galectin-9-sensitive CD4+FoxP3+TIM-3+ population of T cells, which arose from CD4+FoxP3+TIM-3- proliferating T cells in vitro and in vivo and were often PD-1+. These cells became very prominent among graft-infiltrating Tregs during allograft response. The frequency and number of TIM-3+ Tregs peaked at the time of graft rejection and declined thereafter. Moreover, these cells also arise in a tolerance-promoting donor-specific transfusion model, representing a pool of proliferating, donor-specific Tregs. Compared with TIM-3- Tregs, TIM-3+ Tregs, which are often PD-1+ as well, exhibited higher in vitro effector function and more robust expression of CD25, CD39, CD73, CTLA-4, IL-10, and TGF-β but not galectin-9. However, these TIM-3+ Tregs did not flourish when passively transferred to newly transplanted hosts. These data suggest that a heretofore unrecognized graft-infiltrating, short-lived subset of Tregs can restrain rejection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci45138

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Anderson AC, Anderson DE. TIM-3 in autoimmu- nity. Curr Opin Immunol. 2006;18(6):665-669.

Cited by

Sorted by citations

Authors
Gupta, S., Thornley, T. B., Gao, W., Larocca, R., Turka, L. A., Kuchroo, V. K., & Strom, T. B.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Strom, Terry B.
Venue
Journal of Clinical Investigation
Published
2012-07-02
Volume
122
Issue
7
Pages
2395-2404
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1982505108
Cited by
139
References
44
Citations by year
2026: 3 · 2025: 7 · 2024: 12 · 2023: 9 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 21 · 2018: 7 · 2017: 12 · 2016: 7 · 2015: 9 · 2014: 8 · 2013: 12 · 2012: 2
FWCI
4.32
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Beth Israel Deaconess Medical Center
  • National Institutes of Health (AI073748, AI041521, NS038037)
  • U.S. Public Health Service (P0AIGF41521)
  • Medical Research Council (MR/J006742/1)
  • National Institute of Allergy and Infectious Diseases (AI-37691, R01AI037691, P01AI041521, AI 41521, P01AI073748)
  • National Institute of Neurological Disorders and Stroke (P01NS038037, R01NS045937)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords
allograft rejection, regulatory T cells, TIM-3, PD-1, Foxp3, galectin-9, T cell exhaustion, transplantation tolerance, graft-infiltrating T cells, donor-specific T cells, CD4+ T cells
MeSH terms
Hepatitis A Virus Cellular Receptor 2, Animals, Cells, Cultured, Graft Rejection, Lymph Nodes, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred DBA, Mice, Transgenic, Receptors, Virus, Spleen, Transplantation, Homologous, CD4 Antigens, Skin Transplantation, Apoptosis, Galectins, Cell Proliferation, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review